Results

Total Results: 2,110 records

Showing results for "risks".

  1. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
    January 01, 2018 - For instance, one report posits three levels of utilization risk: the low risk patient, the rising-risk … patient and the high-risk patient.24 Rising risk refers to patients who have multiple risk factors … months after the date of service, making them less useful for both assessing and addressing current risks … Data must be available as soon as possible to provide for ongoing care planning and identifying new risks … Managing the risks of healthcare reform: Using risk adjustment and predictive methodologies to drive
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-prevention-covid-surveillance-report.pdf
    July 17, 2020 - of SARS-CoV-2 infection Insufficient evidence to determine effects of masks on risk of SARS-CoV … in moderate or higher risk settings. … in lower risk (outpatient) settings. … One new observational study1 on mask use and risk of SARS-CoV-2 infection in community settings was … There was no association between mask use after illness onset in the index case and risk of SARS-CoV
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy-executive-summary.pdf
    May 01, 2023 - regimens o Lower-dose MgSO4 regimens, compared with standard dose regimens:  May increase the risk … We assessed the risk of bias and evaluated the SoE using standard methods. … difference in the rate of initiation of antihypertensive medications (reported adjusted odds ratio [OR] and relativerisk [RR] = 1.0; other measures of BP management were sparsely reported). … of recurrent seizures (Moderate SoE) but not the risk of death (Low SoE).
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
    June 06, 2011 - Coronary angiography is generally indicated in patients who have chest pain and are at high risk for … For intermediate-risk patients, clinicians have a wide range of noninvasive diagnostic modalities to … Risk stratification/prognostic information? b. … KQ 4: Are there significant safety concerns/risks (i.e., radiation exposure, access site complications … of life in the population of interest) (KQ 3); and whether there are significant safety concerns or risks
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
    March 01, 2022 - There may be a large increased risk of dizziness and sedation, and a moderate increased risk of nausea … -point scale • SMD >0.8 • RR/OR ≥2.0 Abbreviations: MD = mean difference; OR = odds ratio; RR = relative … confidence interval; KQ = Key Question; MD = mean difference; RCT = randomized controlled trial; RR = relative … ; KQ = Key Question; MD = mean difference; OR = odds ratio; RCT = randomized controlled trial; RR = relative … General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
    February 07, 2025 - We will assess the risk of bias for RCTs using the Cochrane Risk of Bias 2 (ROB2) and NRSIs (including … As different outcomes and results from the same study may reflect different risks of bias (e.g., objective … yields a higher SOE rating than a set of studies at moderate or high risk of bias. … of bias is comparable to an RCT at low risk of bias. … RoB 2: a revised tool for assessing risk of bias in randomised trials.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
    November 22, 2011 - adequately precise o Studies that report or allow for the calculation of sensitivity or specificity, relative … comparative effectiveness with adequate precision o Studies that report or allow for the calculation of relative … , specificity, measures of variability), metrics of predictive ability (sensitivity, specificity, relative … performance 40 ) and relative-risk metrics (e.g., odds ratios or hazard ratios comparing outcomes … risk metrics (odds ratios, risk rations, hazard ratios) for clinical outcomes, will be undertaken
  8. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
    October 01, 2009 - dysfunction or heart failure was no better than the use of captopril alone and carried an increased risk … Key Question 4 ACE inhibitors or ARBs significantly increase the risk of withdrawing due to adverse … The ACE inhibitor ramipril and the ARB telmisartan have similar efficacy, similar risks of harms, and … better in lower risk patients while ACE inhibitors work better in higher risk patients. … Perhaps the lowest risk group was least likely to receive aspirin therapy.
  9. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_executive.pdf
    September 01, 2009 - from medications to reduce risk of breast cancer? … Raloxifene does not increase risk for cataracts or cataract surgery. … Clinical risk assessment models to identify women who could benefit from medications to reduce risk of … breast cancer: • Nine risk stratification models that predict an individual’s risk for developing breast … Models consider multiple risk factors for breast cancer.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - hours, the combined treatment group reported significantly more patients with improved function (RR [relative … nonsteroidal anti-inflammatory drug; QoL = quality of life; RCT = randomized clinical trial; RR = relative … Low risk Low risk Low risk Hodgson, 20219 Low risk Low risk Low risk Low risk Low risk Low risk … Low risk Moderate risk Low risk Lipton, 202112 Low risk Low risk Low risk Low risk Low risk Low riskrisk Low risk Low risk Low risk Sakai, 202116 Low risk Low risk Low risk Low risk Low risk Low risk
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
    November 01, 2013 - Assessment of Risk of Bias To assess the risk of bias for individual studies, we followed the methods … Added Value of BNP to Prognostic Risk Prediction. … Relative risks, confidence intervals, and SOE are presented in Table B. … heart failure IMprove heart fAilure morbidity and mortality; RCT = randomized controlled trial; RR = relative … and any other established risk markers.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-disposition-comments.pdf
    December 21, 2023 - Our focus was on risk factors for maternal health. … others to engage sharing knowledge and letting others share there feed back and voice The less the risks … Several studies looked at the protective and risk factors together. … somewhat connected with efforts to consolidate resources and experience, we have become more aware of the risks … Public Commenter #11 Tammy Hall Discussion The risk is major Thank you for the comment.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
    January 27, 2012 - whom acamprosate and oral naltrexone are not suitable or who prefer disulfiram and understand the relativerisks of taking the drug; and (3) to have specialist and competent staff administer pharmacological … Risk-of-Bias Assessment of Individual Studies To assess the risk of bias (internal validity) of studies … the risk of bias for each study. … between acamprosate and naltrexone, whereas the risks of headache and vomiting were higher for those
  14. effectivehealthcare.ahrq.gov/sites/default/files/ch_9-user-guide-to-ocer_130129.pdf
    September 21, 2012 - Effect of Interest Therapy 1 Risk Therapy 2 Risk Desired Power Needed Study Size Needed Recruitment … The effect of interest is specified as a risk ratio. … (10.54 percent), a clinically important excess risk. … For example, database studies may identify small excess risks of about 5 percent that would fall below … Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amendment.pdf
    May 02, 2025 - We will assess the risk of bias for RCTs using the Cochrane Risk of Bias 2 (ROB2) and NRSIs (including … As different outcomes and results from the same study may reflect different risks of bias (e.g., objective … yields a higher SOE rating than a set of studies at moderate or high risk of bias. … of bias is comparable to an RCT at low risk of bias. … RoB 2: a revised tool for assessing risk of bias in randomised trials.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
    December 31, 2022 - risk of infection in people who have never been infected? … Impact of Omicron and Delta variants on risk of reinfection. … Overall, the relative risk of infection was 0.16 (95% CI: 0.14, 0.18) for seropositive individuals versus … risk of infection in people who have never been infected? … Comparative analysis of the risks of hospitalisation and death associated with SARS- CoV-2 omicron (
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
    March 25, 2012 - While hormone therapy is an effective treatment for menopausal symptoms, concerns about potential risks … most women, the potential benefits of hormone therapy given for a clear indication are many and the risks … When there is suggestion or suspicion of effects dependent on baseline risks, potential effects will … Duration of menopausal hot flushes and associated risk factors. … Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - health outcomes) and KQ3 (adverse events), the conclusions are possibly out of date - Teratogenic risks … indicating that hypotension is an unusual side effect for oral antiepileptic drugs, whereas teratogenic risks … The expert emphasized that the large amount of new information on pregnancy outcome risks in women … , questioned the choice of side effects to review and thought it is inexcusable that teratogenic risks … specifying that it can cause fetal harm when administered to a pregnant woman, and the benefits and risks
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - health outcomes) and KQ3 (adverse events), the conclusions are possibly out of date - Teratogenic risks … indicating that hypotension is an unusual side effect for oral antiepileptic drugs, whereas teratogenic risks … The expert emphasized that the large amount of new information on pregnancy outcome risks in women … , questioned the choice of side effects to review and thought it is inexcusable that teratogenic risks … specifying that it can cause fetal harm when administered to a pregnant woman, and the benefits and risks
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-choosing-outcomes.ppt
    June 01, 2012 - Outcomes may affect the balance of test benefits/risks. … These outcomes may affect the balance between the benefits and risks of a test. … Low risk for preterm delivery Average risk for preterm delivery High risk for preterm delivery … , including a procedural risk that computerized tomography does not have. … In this example, the comparison test carries comparable or greater risks.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: